Cargando…
Lessons from Theranos – Restructuring Biomedical Innovation
After raising more than $700 million, Elizabeth Holmes, the founder and chief executive officer of a healthcare startup once valued at $10 billion, was found guilty on four charges of defrauding investors. Founded in 2003, Theranos Inc. was a privately held corporation that aimed to disrupt the diag...
Autores principales: | Das, Rishub Karan, Drolet, Brian Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979578/ https://www.ncbi.nlm.nih.gov/pubmed/35378645 http://dx.doi.org/10.1007/s10916-022-01813-3 |
Ejemplares similares
-
The post-Theranos world
Publicado: (2022) -
Theranos and the scientific community: at the bleeding edge
por: The Lancet
Publicado: (2022) -
Startup Ethics: Ethically Responsible Conduct of Scientists and Engineers at Theranos
por: McGinn, Robert E.
Publicado: (2022) -
Prediction of junior faculty success in biomedical research: comparison of metrics and effects of mentoring programs
por: von Bartheld, Christopher S., et al.
Publicado: (2015) -
Understanding patient partnership in health systems: lessons from the Canadian patient partner survey
por: Abelson, Julia, et al.
Publicado: (2022)